Viewing Study NCT02406833


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-04-20 @ 3:15 PM
Study NCT ID: NCT02406833
Status: COMPLETED
Last Update Posted: 2018-02-28
First Post: 2015-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy
Sponsor: Isarna Therapeutics GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module